Response to neoadjuvant chemoradiotherapy for rectal adenocarcinoma: A single center experience
Response to neoadjuvant chemoradiotherapy for rectal adenocarcinoma: A single center experience Autor: Marin Šunjić
ANGIOMYXOMA TESTIS: A rare case
ANGIOMYXOMA TESTIS: A rare case Autor: Vladimir Ferenčak
Multidisciplinary surgical approach to the treatment of renal cell cancer stage T3c
Multidisciplinary surgical approach to the treatment of renal cell cancer stage T3c Autor: Vladimir Ferenčak
Could ratio of untreated/treated patients with metastatic colorectal carcinoma indicate it`s quality of care?
Could ratio of untreated/treated patients with metastatic colorectal carcinoma indicate it`s quality of care? Autor: Dora Čerina
Immunotherapy in treatment of metastatic melanoma at University Hospital Center Sestre Milosrdnice
Immunotherapy in treatment of metastatic melanoma at University Hospital Center Sestre Milosrdnice Autor: Kristina Urch
Regulation of PD-1/PD-L1 pathway in malignant melanoma – a pilot study
Regulation of PD-1/PD-L1 pathway in malignant melanoma – a pilot study Autor: Damir Vučinić
Melena caused by gastric lipoma
Melena caused by gastric lipoma Autor: Tomislav Pavlović
Early experience with neoadjuvant chemotherapy in musle-invasive bladder cancer: results from single institution retrospective evaluation
Early experience with neoadjuvant chemotherapy in musle-invasive bladder cancer: results from single institution retrospective evaluation Autor: Angela Prgomet
Institutional data on survival and disease control for early and locally advanced breast cancer patients in the era conservative surgical and adjuvant oncological approaches
Institutional data on survival and disease control for early and locally advanced breast cancer patients in the era conservative surgical and adjuvant oncological approaches Autor: Ana Car Peterko
Assessment of creatinine level rise in cancer patients treated with ribociclib and antihormonal therapy at the University Hospital for Tumors
Assessment of creatinine level rise in cancer patients treated with ribociclib and antihormonal therapy at the University Hospital for Tumors Autor: Petra Lepetić
